help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rickenlund, A.
Right arrow Articles by Hirschberg, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rickenlund, A.
Right arrow Articles by Hirschberg, A. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
*TESTOSTERONE
Medline Plus Health Information
*Menstruation
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 702-707
Copyright © 2004 by The Endocrine Society

Diurnal Profiles of Testosterone and Pituitary Hormones Suggest Different Mechanisms for Menstrual Disturbances in Endurance Athletes

Anette Rickenlund, Marja Thorén, Kjell Carlström, Bo von Schoultz and Angelica Lindén Hirschberg

Departments of Obstetrics and Gynecology (A.R., B.v.S., A.L.H.) and Endocrinology and Diabetology (M.T.), Karolinska Hospital; and Department of Obstetrics and Gynecology (K.C.), Huddinge University Hospital, SE-17176 Stockholm, Sweden

Address all correspondence and requests for reprints to: Anette Rickenlund, M.D., Research Laboratory for Reproductive Health, Department of Obstetrics and Gynecology, C4-U1, Karolinska Hospital, SE-17176 Stockholm, Sweden. E-mail: anette.rickenlund{at}ks.se.

The aim of this study was to evaluate the diurnal pattern of testosterone and pituitary hormones in endurance female athletes with different types of menstrual disorder. Age- and body mass index-matched groups of endurance athletes with amenorrhea (n = 10) and oligomenorrhea (n = 6), regularly cycling athletes (n = 8), and sedentary controls (n = 8) were compared with respect to 24-h hormonal profiles of testosterone, LH, prolactin (PRL), GH, insulin, IGF binding protein 1 (IGFBP-1), and cortisol. The 24-h hormone profiles in amenorrheic athletes were characterized by decreased LH pulsatility and peak amplitude of PRL and increased baseline levels of GH and cortisol. However, oligomenorrheic athletes displayed a significantly different pattern with higher diurnal testosterone secretion than all other groups. Furthermore, LH, PRL, GH, and cortisol secretions were comparable with regularly menstruating subjects. In the combined group of athletes with menstrual disturbances, diurnal secretions of testosterone, LH, and PRL were positively, whereas cortisol was negatively correlated with the number of menstruations the last year. Although this could be explained by a gradual inhibition of the hypothalamic-pituitary-gonadal axis, our results indicate that the symptoms of amenorrhea and oligomenorrhea may reflect two hormonally distinct conditions. Thus, amenorrheic athletes displayed a hormonal pattern in agreement with hypothalamic inhibition due to energy deficiency, whereas oligomenorrheic athletes demonstrated increased diurnal secretion of testosterone, suggesting a different mechanism, e.g. essential hyperandrogenism.

This work was supported by the Swedish Medical Research Council (05982, 13142), Center for Sports Research, and Karolinska Institutet.

Abbreviations: AM, Athlete with amenorrhea; AUC, area under curve; BMD, bone mineral areal density; BMI, body mass index; CTR, sedentary regularly menstruating control; HPG, hypothalamic-pituitary-gonadal; IGFBP, IGF binding protein; LBM, lean body mass; OM, athlete with oligomenorrhea; PCO, polycystic ovary; PRL, prolactin; RM, regularly menstruating athlete; VO2 max, maximal oxygen uptake.




This article has been cited by other articles:


Home page
Hum ReprodHome page
A. Rickenlund, M. Thoren, A. Nybacka, J. Frystyk, and A. Linden Hirschberg
Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance
Hum. Reprod., October 19, 2009; (2009) dep350v1.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
R. I. Holt
Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists
J Psychopharmacol, March 1, 2008; 22(2_suppl): 28 - 37.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. K. Miller, E. A. Lawson, V. Mathur, T. L. Wexler, E. Meenaghan, M. Misra, D. B. Herzog, and A. Klibanski
Androgens in Women with Anorexia Nervosa and Normal-Weight Women with Hypothalamic Amenorrhea
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1334 - 1339.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Rickenlund, M. J. Eriksson, K. Schenck-Gustafsson, and A. L. Hirschberg
Oral Contraceptives Improve Endothelial Function in Amenorrheic Athletes
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3162 - 3167.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Rickenlund, M. J. Eriksson, K. Schenck-Gustafsson, and A. L. Hirschberg
Amenorrhea in Female Athletes Is Associated with Endothelial Dysfunction and Unfavorable Lipid Profile
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1354 - 1359.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society